Tom van Wezel

10.9k citations

196 papers · 5.9k · h-index 42

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer

Papers in

Pathology and Forensic Medicine 80
- Genetic factors in colorectal cancer 73
Cancer Research 61
- Cancer Genomics and Diagnostics 49

Co-authors: Hans Morreau (102 shared papers)Ronald van Eijk (46 shared papers)Dina Ruano (36 shared papers)Jan Oosting (24 shared papers)Noel F.C.C. de Miranda (22 shared papers)Frederik J. Hes (30 shared papers)Marjo van Puijenbroek (18 shared papers)Vincent T.H.B.M. Smit (12 shared papers)
Journals: Familial Cancer (10 papers)PLoS ONE (9 papers)BMC Cancer (9 papers)European Journal of Human Genetics (8 papers)Gastroenterology (8 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Tom van Wezel

187 papers receiving 5.8k citations

Peers

Countries citing papers authored by Tom van Wezel

Since Specialization

Citations

This map shows the geographic impact of Tom van Wezel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom van Wezel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom van Wezel more than expected).

Fields of papers citing papers by Tom van Wezel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom van Wezel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom van Wezel. The network helps show where Tom van Wezel may publish in the future.

Co-authors

The 25 scholars most cited alongside Tom van Wezel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom van Wezel Line = papers co-authored together Tom van Wezel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer Science ·Jarno Drost, Ruben van Boxtel, Francis Blokzijl, Tomohiro Mizutani, Nobuo Sasaki, Valentina Sasselli, Joep de Ligt, Sam Behjati, Judith E. Grolleman, Tom van Wezel, Serena Nik‐Zainal, Roland P. Kuiper, Edwin Cuppen, Hans Clevers	2017	320
2	E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines British Journal of Cancer ·Marcel Lombaerts, Tom van Wezel, Katja Philippo, Jan Willem F Dierssen, R M E Zimmerman, Jan Oosting, Ronald van Eijk, Paul H.C. Eilers, Bob van de Water, Cees J. Cornelisse, A-M Cleton-Jansen	2006	278
3	Practical guidance for mismatch repair-deficiency testing in endometrial cancer Annals of Oncology ·Ellen Stelloo, Anna M. Jansen, Elisabeth M. Osse, Remi A. Nout, Carien L. Creutzberg, Dina Ruano, David N. Church, Hans Morreau, Vincent T.H.B.M. Smit, Tom van Wezel, Tjalling Bosse	2016	235
4	Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers Nature Genetics ·Claudia Ruivenkamp, Tom van Wezel, Carlo Zanon, Alphons P. M. Stassen, Čestmı́r Vlček, Tamás Csikós, Anita Klous, Nikos Tripodis, Anastassis Perrakis, Lucie Boerrigter, Peter C. Groot, J. Lindeman, Wolter J. Mooi, Gerrit A. Meijjer, Gert Scholten, Hans G. Dauwerse, Václav Pačes, Nico van Zandwijk, G.J.B. van Ommen, Peter Démant	2002	188
5	Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR PLoS ONE ·Ronald van Eijk, Jappe Licht, Melanie Schrumpf, Mehrdad Talebian Yazdi, Dina Ruano, Giusi Irma Forte, Petra M. Nederlof, Maud Veseliç, Klaus F. Rabe, Jouke T. Annema, Vincent T.H.B.M. Smit, Hans Morreau, Tom van Wezel	2011	149
6	Loss of SMAD4 Alters BMP Signaling to Promote Colorectal Cancer Cell Metastasis via Activation of Rho and ROCK Gastroenterology ·Philip W. Voorneveld, Liudmila L. Kodach, Rutger J. Jacobs, Nalan Liv, A.C. Zonnevylle, Jacob P. Hoogenboom, Izäk Biemond, Hein W. Verspaget, Daniël W. Hommes, Karien E. de Rooij, Carel J.M. van Noesel, Hans Morreau, Tom van Wezel, G. Johan A. Offerhaus, Gijs R. van den Brink, Maikel P. Peppelenbosch, Peter ten Dijke, James C.H. Hardwick	2014	146
7	Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance Clinical Cancer Research ·Linda S. Nooij, Natalja T. ter Haar, Dina Ruano, Natalia Rakislova, Tom van Wezel, Vincent T.H.B.M. Smit, Baptist Trimbos, Jaume Ordï, Mariëtte I.E. van Poelgeest, Tjalling Bosse	2017	120
8	Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway Gut ·Liudmila L. Kodach, Rutger J. Jacobs, Philip W. Voorneveld, Manon E. Wildenberg, (unknown), Tom van Wezel, Hans Morreau, (unknown), Maikel P. Peppelenbosch, Gijs R. van den Brink, James C.H. Hardwick	2011	117
9	Gene interaction and single gene effects in colon tumour susceptibility in mice Nature Genetics ·Tom van Wezel, Alphons P. M. Stassen, Corina J.A. Moen, Augustinus A. M. Hart, Martin A. van der Valk, Peter Démant	1996	113
10	Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers European Journal of Human Genetics ·Anne M.L. Jansen, Tom van Wezel, Brendy EWM van den Akker, Marina Ventayol García, Dina Ruano, Carli M.J. Tops, Anja Wagner, Tom G.W. Letteboer, E. Gómez, Peter Devilee, Juul Wijnen, Frederik J. Hes, Hans Morreau	2015	97
11	HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression BMC Cancer ·Jan Willem F Dierssen, Noel F.C.C. de Miranda, Soldano Ferrone, Marjo van Puijenbroek, Cees J. Cornelisse, Gert Jan Fleuren, Tom van Wezel, Hans Morreau	2007	89
12	Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment Cancer Research ·Yvonne Schrage, Inge H. Briaire‐de Bruijn, Noel F.C.C. de Miranda, Jolieke G. van Oosterwijk, Antonïe H.M. Taminiau, Tom van Wezel, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée	2009	85
13	Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer European Journal of Human Genetics ·Fadwa A. Elsayed, C. Marleen Kets, Dina Ruano, Brendy van den Akker, Arjen R. Mensenkamp, Melanie Schrumpf, Maartje Nielsen, Juul Wijnen, Carli M.J. Tops, Marjolijn J. L. Ligtenberg, Hans F. A. Vasen, Frederik J. Hes, Hans Morreau, Tom van Wezel	2014	83
14	Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer JAMA Internal Medicine ·Marlies S. Reimers, Esther Bastiaannet, Ruth E. Langley, Ronald van Eijk, Ronald L. P. van Vlierberghe, V.E.P.P. Lemmens, Myrthe P. P. van Herk‐Sukel, Tom van Wezel, Riccardo Fodde, Peter J.K. Kuppen, Hans Morreau, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers	2014	82
15	Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma Genes Chromosomes and Cancer ·Akash Mehta, Ekaterina S. Jordanova, Willem E. Corver, Tom van Wezel, Hae‐Won Uh, Gemma G. Kenter, Gert Jan Fleuren	2009	79
16	Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing Journal of Molecular Diagnostics ·Suk Wai Lam, Anne‐Marie Cleton-Jansen, Arjen H.G. Cleven, Dina Ruano, Tom van Wezel, Károly Szuhai, Judith V.M.G. Bovée	2018	79
17	Genetic variation of antigen processing machinery components and association with cervical carcinoma Genes Chromosomes and Cancer ·Akash Mehta, Ekaterina S. Jordanova, Tom van Wezel, Hae‐Won Uh, Willem E. Corver, Kitty M.C. Kwappenberg, Willem Verduijn, Gemma G. Kenter, Sjoerd H. van der Burg, Gert Jan Fleuren	2007	78
18	Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing Journal of Thoracic Oncology ·Daniëlle Cohen, Liesbeth M. Hondelink, Nienke Solleveld‐Westerink, Sandra M. Uljee, Dina Ruano, Anne‐Marie Cleton-Jansen, Jan H. von der Thüsen, S.R.S. Ramai, Pieter E. Postmus, J. Frans Graadt van Roggen, Bart P.C. Hoppe, P C Clahsen, K.W. Maas, Els J. M. Ahsmann, Alexandra ten Heuvel, Frank Smedts, Ronald N. van Rossem, Tom van Wezel	2020	78
19	DNA repair genes are selectively mutated in diffuse large B cell lymphomas The Journal of Experimental Medicine ·Noel F.C.C. de Miranda, Roujun Peng, Κωνσταντίνος Γεωργίου, Chenglin Wu, Elin Falk Sörqvist, Mattias Berglund, Longyun Chen, Zhibo Gao, Kristina Lagerstedt‐Robinson, Susana Lisboa, Fredrik Roos, Tom van Wezel, Manuel R. Teixeira, Richard Rosenquist, Christer Sundström, Gunilla Enblad, Mats Nilsson, (unknown), David Kipling, Qiang Pan‐Hammarström	2013	77
20	Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy Clinical Cancer Research ·Yixiang Zhang, Jolieke G. van Oosterwijk, Ewa Sicińska, Samuel Moss, Stephen P. Remillard, Tom van Wezel, Claudia Bühnemann, A. Bassim Hassan, George D. Demetri, Judith V.M.G. Bovée, Andrew J. Wagner	2013	76

About Tom van Wezel

Tom van Wezel is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Molecular Biology and Genetics, having authored 196 papers that have together received 5.9k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (73 papers), Cancer Genomics and Diagnostics (49 papers), Colorectal Cancer Treatments and Studies (16 papers), BRCA gene mutations in cancer (12 papers), Thyroid Cancer Diagnosis and Treatment (12 papers), Colorectal Cancer Screening and Detection (11 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Cancer Research (1.5k citations), Pathology and Forensic Medicine (1.5k citations), Oncology (1.8k citations), Molecular Biology (2.1k citations) and Obstetrics and Gynecology (201 citations). Tom van Wezel has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Hans Morreau, Ronald van Eijk, Dina Ruano, Jan Oosting, Noel F.C.C. de Miranda, Frederik J. Hes, Marjo van Puijenbroek, Vincent T.H.B.M. Smit, Willem E. Corver and Gert Jan Fleuren. Their work appears in journals such as Familial Cancer, PLoS ONE, BMC Cancer, European Journal of Human Genetics and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Tom van Wezel

Impact in

Papers in i

In The Last Decade

Tom van Wezel

Peers

Countries citing papers authored by Tom van Wezel

Fields of papers citing papers by Tom van Wezel

All Works

About Tom van Wezel

Explore authors with similar magnitude of impact

Papers in